Search for Clinical Trial Results
Carcinoma, Islet Cell - 25 Studies Found
Status | Study |
Completed |
Study Name: Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy Condition:
|
Withdrawn |
Study Name: Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy Condition:
|
Recruiting |
Study Name: FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas Condition:
|
Completed |
Study Name: Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma Condition:
|
Completed |
Study Name: Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors Condition:
|
Recruiting |
Study Name: Clinical Evaluation of i-STAT Analyzer Condition:
|
Active, not recruiting |
Study Name: Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Condition:
|
Active, not recruiting |
Study Name: Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Condition:
|
Withdrawn |
Study Name: Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors Condition:
|
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition:
|